Track topics on Twitter Track topics that are important to you
The global polycystic ovary syndrome treatment market is predicted to be worth $5.1 billion by 2025, up from $3.3 billion in 2016, according to a report from Grand View Research.
PCOS is the most common cause of female infertility, affecting from 6% to 12% of reproductive age women, according to a press release from Grand View Research.
There are currently no drugs specifically available for PCOS, but drug classes often used to address symptoms include anti-androgens, antidepressants, anti-obesity agents, oral contraceptives and insulin-sensitizing agents. Insulin-sensitizing agents currently
Original Article: PCOS treatment market worth over $5 billion by 2025NEXT ARTICLE
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...